Treatment of hypertension by renal vascular delivery of guanethidine
First Claim
1. A method for treating hypertension in a patient, said method comprising the delivering of an amount of guanethidine to the nerves surrounding a blood vessel, wherein delivery comprises injecting guanethidine into tissue bound on the inside by the external elastic lamina of said blood vessel and bound on the outside by the outer extent of the adventitial and perivascular connective tissues that surround the blood vessel, wherein the amount is effective to lower systemic blood pressure by a therapeutically beneficial amount.
1 Assignment
0 Petitions
Accused Products
Abstract
Sympathetic nerves run through the adventitia surrounding renal arteries and are critical in the modulation of systemic hypertension. Hyperactivity of these nerves can cause renal hypertension, a disease prevalent in 30-40% of the adult population. Hypertension can be treated with neuromodulating agents (such as angiotensin converting enzyme inhibitors, angiotensin II inhibitors, or aldosterone receptor blockers), but requires adherence to strict regimens and often does not reach target blood pressure threshold to reduce risk of major cardiovascular events. A minimally invasive solution is presented here to reduce the activity of the sympathetic nerves surrounding the renal artery by locally delivering neurotoxic or sympathetic nerve-blocking agents into the adventitia. Extended elution of these agents may also be accomplished in order to tailor the therapy to the patient.
-
Citations
18 Claims
- 1. A method for treating hypertension in a patient, said method comprising the delivering of an amount of guanethidine to the nerves surrounding a blood vessel, wherein delivery comprises injecting guanethidine into tissue bound on the inside by the external elastic lamina of said blood vessel and bound on the outside by the outer extent of the adventitial and perivascular connective tissues that surround the blood vessel, wherein the amount is effective to lower systemic blood pressure by a therapeutically beneficial amount.
Specification